Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy
ACS Nano · 2024
DOI: 10.1021/acsnano.3c12678 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Jing Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Chicago, 929 East 57th Street, Chicago, Illinois 60637, United States. Hauptthemen laut MEDLINE: B7-H1 Antigen, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Chicago, 929 East 57th Street, Chicago, Illinois 60637, United States.
- Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, University of Chicago, 5758 South Maryland Avenue, Chicago, Illinois 60637, United States.
ORCID-Profile: Jing Liu, Xiaomin Jiang, Wenbin Lin
Förderung
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Liu, J., Jiang, X., Li, Y., Yang, K., Weichselbaum, R. R., & Lin, W. (2024). Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.3c12678
Vancouver
Liu J, Jiang X, Li Y, Yang K, Weichselbaum RR, Lin W. Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy. ACS Nano. 2024. doi:10.1021/acsnano.3c12678
BibTeX
@article{Liu2024,
author = {Liu, Jing and Jiang, Xiaomin and Li, Youyou and Yang, Kaiting and Weichselbaum, Ralph R and Lin, Wenbin},
title = {Immunogenic Bifunctional Nanoparticle Suppresses Programmed Cell Death-Ligand 1 in Cancer and Dendritic Cells to Enhance Adaptive Immunity and Chemo-Immunotherapy},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.3c12678}
}
EUVIMED